These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31094024)

  • 1. Efficacy of acotiamide hydrochloride hydrate added to α-blocker plus cholinergic drug combination therapy.
    Sugimoto K; Akiyama T; Matsumura N; Minami T; Uejima S; Uemura H
    Int J Urol; 2019 Aug; 26(8):848-849. PubMed ID: 31094024
    [No Abstract]   [Full Text] [Related]  

  • 2. Are There Pharmacotherapeutic Options for Underactive Bladder?
    Osman NI; Chapple CR
    Eur Urol Focus; 2018 Jan; 4(1):6-7. PubMed ID: 29776685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excitatory effect of acotiamide on rat and human bladder: Implications for underactive bladder treatment.
    Singh N; Mizoguchi S; Suzuki T; Zabbarova I; Ikeda Y; Kanai A; Chermansky C; Yoshimura N; Tyagi P
    Life Sci; 2020 Oct; 258():118179. PubMed ID: 32758626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of a cholinergic drug and an alpha-blocker is more effective than monotherapy for the treatment of voiding difficulty in patients with underactive detrusor.
    Yamanishi T; Yasuda K; Kamai T; Tsujii T; Sakakibara R; Uchiyama T; Yoshida K
    Int J Urol; 2004 Feb; 11(2):88-96. PubMed ID: 14706012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detrusor Underactivity and the Underactive Bladder: A Systematic Review of Preclinical and Clinical Studies.
    Osman NI; Esperto F; Chapple CR
    Eur Urol; 2018 Nov; 74(5):633-643. PubMed ID: 30139634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacological and clinical profile of acotiamide hydrochloride hydrate (Acofide(®) Tablets 100 mg), a novel therapeutic agent for functional dyspepsia (FD)].
    Matsunaga Y; Tanaka T; Saito Y; Kato H; Takei M
    Nihon Yakurigaku Zasshi; 2014 Feb; 143(2):84-94. PubMed ID: 24531902
    [No Abstract]   [Full Text] [Related]  

  • 7. Pirfenidone improves voiding function by suppressing bladder fibrosis in underactive bladder rats.
    Ko IG; Hwang L; Jin JJ; Kim SH; Kim CJ; Choi YH; Kim HY; Yoo JM; Kim SJ
    Eur J Pharmacol; 2024 Aug; 977():176721. PubMed ID: 38851561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mirabegron (Myrbetriq) for overactive bladder.
    Med Lett Drugs Ther; 2013 Feb; 55(1410):13-5. PubMed ID: 23459457
    [No Abstract]   [Full Text] [Related]  

  • 9. Is Urodynamics Necessary when Assessing a Patient with Male Lower Urinary Tract Symptoms?
    Drake MJ
    Eur Urol Focus; 2018 Jan; 4(1):54-56. PubMed ID: 29705282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of meal-related symptoms and epigastric pain in patients with functional dyspepsia treated with acotiamide was associated with acylated ghrelin levels in Japan.
    Yamawaki H; Futagami S; Kawagoe T; Maruki Y; Hashimoto S; Nagoya H; Sato H; Kodaka Y; Gudis K; Akamizu T; Sakamoto C; Iwakiri K
    Neurogastroenterol Motil; 2016 Jul; 28(7):1037-47. PubMed ID: 26920949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-World, Non-Interventional, Observational Study to Evaluate Effectiveness and Tolerability of Acotiamide Hydrochloride Hydrate in Treatment of Functional Dyspepsia.
    Porika SK; Veligandla KC; Muni SK; Acharya S; Mehta SC; Sharma AD
    Adv Ther; 2018 Nov; 35(11):1884-1893. PubMed ID: 30350248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy of gastroesophageal reflux disease and functional dyspepsia overlaps with symptoms after usual-dose proton pump inhibitor: Acotiamide plus usual-dose proton pump inhibitor versus double-dose proton pump inhibitor.
    Takeuchi T; Takahashi Y; Kawaguchi S; Ota K; Harada S; Kojima Y; Sakamoto H; Kuramoto T; Kojima K; Sanomura M; Hoshimoto M; Higashino T; Itabashi T; Takada K; Sakaguchi M; Tominaga K; Kusano M; Higuchi K
    J Gastroenterol Hepatol; 2018 Mar; 33(3):623-630. PubMed ID: 28865098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of combined therapy with tamsulosin hydrochloride and meloxicam in patients with benign prostatic hyperplasia symptoms and impact on nocturia and sleep quality.
    Gorgel SN; Sefik E; Kose O; Olgunelma V; Sahin E
    Int Braz J Urol; 2013; 39(5):657-62. PubMed ID: 24267123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of solifenacin plus tamsulosin OCAS in men with voiding and storage lower urinary tract symptoms: results from a phase 2, dose-finding study (SATURN).
    Van Kerrebroeck P; Haab F; Angulo JC; Vik V; Katona F; Garcia-Hernandez A; Klaver M; Traudtner K; Oelke M
    Eur Urol; 2013 Sep; 64(3):398-407. PubMed ID: 23537687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New therapeutic directions to treat underactive bladder.
    Chai TC; Kudze T
    Investig Clin Urol; 2017 Dec; 58(Suppl 2):S99-S106. PubMed ID: 29279882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical efficacy of oxendolene (antiandrogen) and bunazosin hydrochloride (alpha-adrenergic blocker) in the treatment of prostatism--comparative study of oxendolone, bunazocin hydrochloride and their combination].
    Kumamoto Y; Tsukamoto T; Takagi Y; Furuya S; Yokoyama E; Takatsuka K; Tamiya T; Miyamoto S; Aoyama T; Honma A
    Hinyokika Kiyo; 1987 Nov; 33(11):1921-41. PubMed ID: 2451412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia - 100 mg t.i.d. is an optimal dosage.
    Matsueda K; Hongo M; Tack J; Aoki H; Saito Y; Kato H
    Neurogastroenterol Motil; 2010 Jun; 22(6):618-e173. PubMed ID: 20059698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Randomized, Double-Blind, Pilot Study of the Effect of Famotidine on Acotiamide Treatment for Functional Dyspepsia.
    Hojo M; Nagahara A; Asaoka D; Takeda T; Izumi K; Matsumoto K; Ueyama H; Shimada Y; Matsumoto K; Nojiri S; Watanabe S
    Digestion; 2017; 96(1):5-12. PubMed ID: 28605740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy and safety of doxazosine in combination with finasteride in the treatment of prostatic adenoma].
    Bogdanov AB; Luk'ianov IV; Veliev EI
    Urologiia; 2008; (6):44-9. PubMed ID: 19248599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravesical Activation of the Cation Channel TRPV4 Improves Bladder Function in a Rat Model for Detrusor Underactivity.
    Deruyver Y; Weyne E; Dewulf K; Rietjens R; Pinto S; Van Ranst N; Franken J; Vanneste M; Albersen M; Gevaert T; Vennekens R; De Ridder D; Voets T; Everaerts W
    Eur Urol; 2018 Sep; 74(3):336-345. PubMed ID: 29875065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.